SC
TLGT

Sophrosyne Capital’s Teligent, Inc TLGT Stock Holding History

Sophrosyne Capital’s Portfolio TLGT Stock Details TLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,250
Closed -$330K – 72
2014
Q2 		$330K Buy
+6,250
New +$319K 0.34% 44

Other funds holding TLGT

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Sophrosyne Capital's TLGT Position: Q3 2014 in Review

Sophrosyne Capital sold out of Teligent, Inc (TLGT) in Q3 2014, closing a stake of 6,250 shares — an estimated $330K sold.

Sophrosyne Capital first reported a position in TLGT in Q2 2014 and held it in 1 quarter. The position peaked at $330K in Q2 2014. 89 funds tracked by Wall St. Rank hold TLGT as of Q3 2014.

  • Sophrosyne Capital reported no remaining Teligent, Inc position as of Q3 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 6,250 Teligent, Inc shares in Q3 2014, an estimated $330K.
  • Sophrosyne Capital first reported a position in Teligent, Inc in Q2 2014 and held it in 1 quarter.
  • Sophrosyne Capital's Teligent, Inc position peaked at $330K in Q2 2014.
  • 89 funds tracked by Wall St. Rank held Teligent, Inc as of Q3 2014.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.